Muhammad Salman Faisal
Overview
Explore the profile of Muhammad Salman Faisal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seghers S, Mando P, Eid M, Tan C, Jayraj A, Jatwani K, et al.
JCO Oncol Pract
. 2025 Feb;
:OP2400739.
PMID: 40014833
Purpose: The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) and the ASCO Value Framework (ASCO-VF) are tools designed to assess the value of anticancer therapies. International conferences...
2.
Ans H, Amjad H, Nazir S, Cheema S, Mistry D, Fatima T, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Jan;
PMID: 39827026
Hematopoietic stem cell transplantation (HSCT) is a potentially curative option for adults with acute lymphoblastic leukemia (ALL) who have achieved remission. This systematic review and meta-analysis compare the efficacy of...
3.
Ichkhanian Y, Chaudhary A, Veracruz N, Faisal M, Peller M, Peller M, et al.
Gastrointest Endosc
. 2025 Jan;
PMID: 39788214
Background And Aims: Efficacy and safety of endoscopic ultrasound (EUS)-guided placement of lumen-apposing metal stents (LAMSs) has been reported, but the advantage of using 15-mm LAMSs over 10-mm LAMSs has...
4.
Shahzad M, Iqbal Q, Amin M, Irfan S, Warraich S, Anwar I, et al.
Leuk Res
. 2024 Dec;
148():107640.
PMID: 39724831
Background: Hematopoietic stem cell transplantation (HCT) is a pivotal treatment modality for primary plasma cell leukemia (pPCL). We aimed to examine the outcomes of allogeneic (allo) and autologous (auto) HCT...
5.
Aqeel S, Faisal M, Akhtar O, Attwood K, George A, Advani P, et al.
Ann Hematol
. 2024 Nov;
103(12):5539-5547.
PMID: 39495284
Data regarding racial disparities in the incidence, treatment, and outcomes of diffuse large B-cell lymphoma (DLBCL) is limited in the adolescent and young adult (AYA) population. We utilized the surveillance,...
6.
Bodla Z, Hashmi M, Niaz F, Auyeung A, Oyetoran A, Khalil M, et al.
Hematol Rep
. 2024 Jul;
16(3):421-430.
PMID: 39051414
This study investigated the impact of COVID-19 on patients with sickle cell crisis (SCC) using National Inpatient Sample (NIS) data for the year 2020. A retrospective cohort analysis was conducted...
7.
Ur Rehman M, Hameed M, Shah Z, Ashruf O, Ali R, Faraz F, et al.
Clin Hematol Int
. 2024 May;
6(1):3-12.
PMID: 38817692
Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma which may predispose individuals to development of secondary malignancies (SMs). The Surveillance, Epidemiology, and End Results (SEER) database is a comprehensive registry...
8.
Malek A, Al-Juhaishi T, Milton D, Ramdial J, Daher M, Olson A, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):699-704.
PMID: 38355908
No abstract available.
9.
Shahzad M, Khalid M, Amin M, Basharat A, Ammad-Ud-Din M, Park R, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Feb;
24(5):316-322.
PMID: 38342727
Background: We investigate the geographical and racial disparities in accessing CAR-T and bispecific antibodies trials for DLBCL. Materials And Methods: ClinicalTrials.gov was searched, and 75 trials with at least 1...
10.
Bajwa R, Kleb C, Faisal M, Khan M, Khan A, Lyu R, et al.
Eur J Gastroenterol Hepatol
. 2023 Dec;
36(2):190-196.
PMID: 38131425
Objective: The purpose of this study was to determine how thromboelastography (TEG) parameters differ by various clinical conditions that commonly occur in patients with cirrhosis, including sepsis, acute on chronic...